Clinical Trials Logo
  1. Home
  2. Ocular Inflammation
  3. NCT03596723

KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

Ocular Inflammation Clinical Trial

Official title:
Safety and Efficacy of KPI-121 1% Ophthalmic Suspension Versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Inflammation Following Cataract Surgery in Children 0 to 3 Years of Age

Clinical Trial Summary

This study is designed to assess how KPI-121 1% compares to prednisolone acetate in reducing inflammation after cataract surgery in young children. Approximately half the participants will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03596723
Study type Interventional
Source Kala Pharmaceuticals, Inc.
Contact
Status Terminated
Phase Phase 3
Start date July 3, 2018
Completion date October 18, 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Not yet recruiting NCT05248139 - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery N/A
Terminated NCT01214174 - Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients Phase 2
Completed NCT03332342 - Closed Eye Neutrophils in Dry Eye Disease N/A
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT01808547 - Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects Phase 3
Active, not recruiting NCT04374656 - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Recruiting NCT05668455 - Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses) Phase 3
Completed NCT00645671 - Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery Phase 3
Completed NCT00789971 - Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification N/A
Completed NCT02786901 - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Phase 3
Completed NCT00699153 - Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery Phase 3
Completed NCT01576952 - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects Phase 3
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03580473 - Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification Phase 2
Completed NCT04812951 - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery Early Phase 1
Completed NCT03302273 - Corneal Epithelial Stem Cells and Dry Eye Disease N/A
Completed NCT04690829 - Biomarkers in Ocular Inflammation and Uveitis
Withdrawn NCT01721694 - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Phase 3
Completed NCT03521791 - Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. Phase 4